Harmony Biosciences Holdings, Inc. (HRMY)

HRMY Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	180.9	145.49	128.85	181.47	34.6	-36.94
Depreciation & Amortization	23.87	24.11	24.36	23.39	18.84	10.24
Other Amortization	0.67	0.7	2.27	1.66	2.24	2.41
Asset Writedown & Restructuring Costs	16	43.6	2.26	-	-	2
Loss (Gain) From Sale of Investments	-1.95	-2.26	-2.72	-0.43	-	-
Stock-Based Compensation	45.07	42.6	31.71	26.17	15.66	4.69
Other Operating Activities	-20.36	-27.1	-2.38	-83.69	26.59	26.25
Change in Accounts Receivable	-9.82	-8.89	-19.4	-19.9	-12.67	-17.92
Change in Inventory	-0.46	-1.84	-1.07	0.14	-0.61	-2.74
Change in Accounts Payable	5.62	-5.38	8.95	2.79	-1.56	-3.8
Change in Other Net Operating Assets	19.82	8.79	46.55	12.87	15.46	12.83
Operating Cash Flow	259.38	219.82	219.39	144.47	98.56	-2.99
Operating Cash Flow Growth	21.48%	0.20%	51.86%	46.58%	-	-
Capital Expenditures	-0.65	-1.15	-0.31	-0.17	-0.3	-0
Cash Acquisitions	-	-33.07	-36.97	-	-	-
Sale (Purchase) of Intangibles	-16	-26.5	-	-40	-100	-2
Investment in Securities	-7.02	-6.76	-9.16	-101.66	-	-
Investing Cash Flow	-23.67	-67.48	-46.44	-141.83	-100.3	-2
Long-Term Debt Issued	-	-	200	-	200	200
Long-Term Debt Repaid	-	-15	-201.25	-2	-200.5	-102.54
Net Debt Issued (Repaid)	-15	-15	-1.25	-2	-0.5	97.46
Issuance of Common Stock	12.62	6.5	5.06	8.84	39.37	147.93
Repurchase of Common Stock	-4.57	-2.5	-100.51	-	-	-0.18
Other Financing Activities	-	-	-8.84	-	-31.45	-36.04
Financing Cash Flow	-6.95	-11	-105.55	6.84	7.42	209.16
Net Cash Flow	228.75	141.34	67.4	9.48	5.68	204.17
Free Cash Flow	258.73	218.67	219.08	144.29	98.26	-2.99
Free Cash Flow Growth	21.59%	-0.19%	51.82%	46.85%	-	-
Free Cash Flow Margin	33.49%	30.59%	37.64%	32.95%	32.17%	-1.87%
Free Cash Flow Per Share	4.44	3.78	3.63	2.36	1.66	-0.12
Cash Interest Paid	16.03	17.32	20.05	16.36	19.83	26.2
Cash Income Tax Paid	72.91	79.64	48.23	12.65	2.88	-
Levered Free Cash Flow	197.81	143.91	214.33	72.97	-123.53	96
Unlevered Free Cash Flow	207.16	154.14	226.91	83.05	-110.64	111.47
Change in Net Working Capital	-16.1	4.29	-51.63	2.19	99.99	-87.43

Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q